HTLV-1 provirus load in peripheral blood lymphocytes of HTLV-1 carriers is diminished by green tea drinking

被引:35
|
作者
Sonoda, J
Koriyama, C
Yamamoto, S
Kozako, T
Li, HC
Lema, C
Yashiki, S
Fujiyoshi, T
Yoshinaga, M
Nagata, Y
Akiba, S
Takezaki, T
Yamada, K
Sonoda, S
机构
[1] Kagoshima Univ, Fac Med, Dept Virol, Kagoshima 8908520, Japan
[2] Kagoshima Univ, Fac Med, Dept Clin Pharmacol, Kagoshima 8908520, Japan
[3] Kagoshima Univ, Fac Med, Dept Publ Hlth, Kagoshima 8908520, Japan
[4] Kagoshima Univ, Fac Med, Dept Gynecol & Obstet, Kagoshima 8908520, Japan
[5] Kagoshima Univ, Fac Med, Dept Int Island & Community Med, Kagoshima 8908520, Japan
关键词
D O I
10.1111/j.1349-7006.2004.tb02493.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Human T-cell lymphotropic virus type 1 (HTLV-1) is causatively associated with adult T-cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Since a high level of HTLV-1 provirus load in circulating lymphocytes is thought to be a risk for ATL and HAM/TSP, diminution of HTLV-1 provirus load in the circulation may prevent these intractable diseases. Our previous study (Jpn J Cancer Res 2000; 91: 34-40) demonstrated that green tea polyphenols inhibit in vitro growth of ATL cells, as well as HTLV-1-infected T-cells. The present study aimed to investigate the in vivo effect of green tea polyphenols on HTLV-1 provirus load in peripheral blood lymphocytes on HTLV-1 carriers. We recruited 83 asymptomatic HTLV-1 carriers to examine HTLV-1 provirus DNA with or without administration of capsulated green tea extract powder. Thirty-seven subjects were followed up for 5 months by measuring HTLV-1 provirus load after daily intake of 9 capsules of green tea extract powder per day (equivalent to 10 cups of regular green tea), and 46 subjects lived ad libitum without intake of any green tea capsule. The real-time PCR quantification of HTLV-1 DNA revealed a wide range of variation of HTLV-1 provirus load among asymptomatic HTLV-1 carriers (0.2-200.2 copies of HTLV-1 provirus load per 1000 peripheral blood lymphocytes). Daily intake of the capsulated green tea for 5 months significantly diminished the HTLV-1 provirus load as compared with the controls (P=0.031). These results suggest that green tea drinking suppresses proliferation of HTLV-1-infected lymphocytes in vivo.
引用
收藏
页码:596 / 601
页数:6
相关论文
共 50 条
  • [21] Antiviral effect of raltegravir on HTLV-1 carriers
    Trevino, Ana
    Parra, Patricia
    Bar-Magen, Tamara
    Garrido, Carolina
    de Mendoza, Carmen
    Soriano, Vincent
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (01) : 218 - 221
  • [22] DEVELOPMENT OF HTLV-1 HYPERIMMUNE GLOBULINS AGAINST HTLV-1 INFECTION
    Mizukami, T.
    Nojima, K.
    Sobata, R.
    Kuribayashi, W.
    Matsumoto, C.
    Sato, Y.
    Sasaki, E.
    Furuhata, K.
    Hiradate, Y.
    Ohkuma, K.
    Matsuoka, S.
    Satake, M.
    Hamaguchi, I.
    HAEMATOLOGICA, 2017, 102 : 140 - 140
  • [23] SCREENING BLOOD-DONORS FOR HTLV-1 - THE VALUE OF EPITOPE MAPPING OF HTLV-1 PROTEINS
    GLEDHILL, S
    LEUKEMIA, 1990, 4 (10) : 725 - 726
  • [24] The estimated number of HTLV-1 carriers in Kagoshima
    Tashiro, Y.
    Matsuura, E.
    Sagara, Y.
    Kubota, R.
    Takashima, H.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 1013 - 1013
  • [25] HTLV-1 AND BLOOD-TRANSFUSION
    BOVE, JR
    SANDLER, SG
    TRANSFUSION, 1988, 28 (02) : 93 - 94
  • [26] Uveitis associated with thyroiditis in HTLV-1 carriers
    Streho, M
    Delair, E
    Abad, S
    Sablé-Fourtassou, R
    Blanche, P
    Monnet, D
    Brion, MC
    Brezin, AP
    Dhote, R
    REVUE DE MEDECINE INTERNE, 2005, 26 (11): : 894 - 896
  • [27] Human T lymphotropic virus type 1 (HTLV-1) proviral load in asymptomatic carriers, HTLV-1 associated myelopathy/tropical spastic paraparesis, and other neurological abnormalities associated with HTLV-1 infection
    Silva, Marcus Tulius T.
    Harab, Ramza Cabral
    Leite, Ana Claudia
    Schor, Doris
    Araujo, Abelardo
    Andrada-Serpa, Maria Jose
    CLINICAL INFECTIOUS DISEASES, 2007, 44 (05) : 689 - 692
  • [28] Deleted HTLV-1 provirus in cord-blood samples of babies born to HTLV-1-carrier mothers
    Kazi, A
    Miyata, H
    Kamahora, T
    Kurokawa, K
    Katamine, S
    Hino, S
    INTERNATIONAL JOURNAL OF CANCER, 1998, 77 (05) : 701 - 704
  • [29] Precise excision of HTLV-1 provirus with a designer-recombinase
    Rojo-Romanos, Teresa
    Karpinski, Janet
    Millen, Sebastian
    Beschorner, Niklas
    Simon, Florian
    Paszkowski-Rogacz, Maciej
    Lansing, Felix
    Schneider, Paul Martin
    Sonntag, Jan
    Hauber, Joachim
    Thoma-Kress, Andrea K.
    Buchholz, Frank
    MOLECULAR THERAPY, 2023, 31 (07) : 2266 - 2285
  • [30] Transcriptional and Epigenetic Regulatory Mechanisms Affecting HTLV-1 Provirus
    Miyazato, Paola
    Matsuo, Misaki
    Katsuya, Hiroo
    Satou, Yorifumi
    VIRUSES-BASEL, 2016, 8 (06):